101. I have NMOSD. Now What?

101. I have MOGAD. Now what?Подробнее

102. Choosing a Long-Term Treatment Option NMOSDПодробнее

303. Understanding Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder: NMO-101Подробнее

NMOSD: The Importance of Early Diagnosis and TreatmentПодробнее

2019 RNDS — The Future of NMOSD Therapeutics: What Have We Learned?Подробнее

Dr. Anu Jacob l NMOSD Therapy UpdateПодробнее

2022 Pre-RNDS | Neuromyelitis Optica Spectrum Disorder (NMOSD)Подробнее

401. Mental Health and NMOSDПодробнее

101. Ask the Expert Podcast in Collaboration with RGIПодробнее

206. History, Diagnosis, and Management of NMOSDПодробнее

New agents under investigation to treat AQP4-positive NMOSDПодробнее

105. Explaining NMOSD to OthersПодробнее

Understanding NMOSD in Relation to Multiple SclerosisПодробнее

2021 RNDS | Neuromyelitis Optica Spectrum Disorder (NMOSD)Подробнее

Advice from a working mother | Ana's NMOSD storyПодробнее

Michelle's NMOSD storyПодробнее

Identifying risk factors for AQP4+ NMOSDПодробнее

Prognostic factors in NMOSD: age, ethnicity, and relapse historyПодробнее

205. MOGAD and NMOSD: Is MOGAD Part of NMOSD or a Distinct Diagnosis?Подробнее